Elgemtumab
Elgemtumab Uses, Dosage, Side Effects, Food Interaction and all others data.
Elgemtumab is under investigation in clinical trial NCT02167854 (Open-Label Study Evaluating the Safety and Tolerability of LJM716, BYL719 and Trastuzumab in Patients With Metastatic HER2+ Breast Cancer).
| Trade Name | Elgemtumab |
| Generic | Elgemtumab |
| Elgemtumab Other Names | Elgemtumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Elgemtumab
